RelAp43, a Member of the NF-κB Family Involved in Innate Immune Response against Lyssavirus Infection

PLoS Pathogens

Volumn 8, Issue 12, 2012, Pages

  Luco, Sophie ^a,b   Delmas, Olivier ^a   Vidalain, Pierre Olivier ^a   Tangy, Frédéric ^a   Weil, Robert ^a   Bourhy, Hervé ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; PROTEIN RELAP43; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; INNATE IMMUNITY; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RABIES; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-1; INTERFERON-BETA; LYSSAVIRUS; MONOSACCHARIDE TRANSPORT PROTEINS; RHABDOVIRIDAE INFECTIONS; TRANSCRIPTION FACTOR RELA;

LYSSAVIRUS;

EID: 84872045833     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003060     Document Type: Article

References (63)

1. Sen R, Baltimore D, (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716.
2. Oeckinghaus A, Hayden MS, Ghosh S, (2011) Crosstalk in NF-kappa B signaling pathways. Nature Immunology 12: 695-708.
3. Leeman JR, Gilmore TD, (2008) Alternative splicing in the NF-kappaB signaling pathway. Gene 423: 97-107.
4. Huang B, Yang XD, Lamb A, Chen LF, (2010) Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway. Cell Signal 22: 1282-1290.
5. Wan F, Lenardo MJ, (2010) The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives. Cell Res 20: 24-33.
6. Wang J, Basagoudanavar SH, Wang X, Hopewell E, Albrecht R, et al. (2010) NF-kappa B RelA subunit is crucial for early IFN-beta expression and resistance to RNA virus replication. J Immunol 185: 1720-1729.
7. Basagoudanavar SH, Thapa RJ, Nogusa S, Wang J, Beg AA, et al. (2011) Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses. J Virol 85: 2599-2610.
8. Taniguchi T, Takaoka A, (2001) A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2: 378-386.
9. Versteeg GA, Garcia-Sastre A, (2010) Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 13: 508-516.
10. Sadler AJ, Williams BR, (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8: 559-568.
11. Wang ZW, Sarmento L, Wang Y, Li XQ, Dhingra V, et al. (2005) Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol 79: 12554-12565.
12. Ge P, Tsao J, Schein S, Green TJ, Luo M, et al. (2010) Cryo-EM model of the bullet-shaped vesicular stomatitis virus. Science 327: 689-693.
13. Graham SC, Assenberg R, Delmas O, Verma A, Gholami A, et al. (2008) Rhabdovirus matrix protein structures reveal a novel mode of self-association. PLoS Pathog 4: e1000251.
14. Finke S, Conzelmann KK, (2005) Replication strategies of rabies virus. Virus Res 111: 120-131.
15. Kucharczak J, Simmons MJ, Fan Y, Gelinas C, (2003) To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 22: 8961-8982.
16. Rayet B, Gelinas C, (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18: 6938-6947.
17. O'Dea E, Hoffmann A, (2010) The regulatory logic of the NF-kappaB signaling system. Cold Spring Harb Perspect Biol 2: a000216.
18. Deloukas P, van Loon AP, (1993) Genomic organization of the gene encoding the p65 subunit of NF-kappa B: multiple variants of the p65 protein may be generated by alternative splicing. Hum Mol Genet 2: 1895-1900.
19. Lyle R, Valleley EM, Sharpe PT, Hewitt JE, (1994) An alternatively spliced transcript, p65 delta 2, of the gene encoding the p65 subunit of the transcription factor NF-kappa B. Gene 138: 265-266.
20. Maxwell SA, Mukhopadhyay T, (1995) A novel NF-kappa B p65 spliced transcript lacking exons 6 and 7 in a non-small cell lung carcinoma cell line. Gene 166: 339-340.
21. Narayanan R, Klement JF, Ruben SM, Higgins KA, Rosen CA, (1992) Identification of a naturally occurring transforming variant of the p65 subunit of NF-kappa B. Science 256: 367-370.
22. Ruben SM, Narayanan R, Klement JF, Chen CH, Rosen CA, (1992) Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative. Mol Cell Biol 12: 444-454.
23. Phan HH, Cho K, Sainz-Lyon KS, Shin S, Greenhalgh DG, (2006) CD14-dependent modulation of NF-kappaB alternative splicing in the lung after burn injury. Gene 371: 121-129.
24. Gregory DJ, Godbout M, Contreras I, Forget G, Olivier M, (2008) A novel form of NF-kappaB is induced by Leishmania infection: involvement in macrophage gene expression. Eur J Immunol 38: 1071-1081.
25. Saccani S, Pantano S, Natoli G, (2003) Modulation of NF-kappaB activity by exchange of dimers. Mol Cell 11: 1563-1574.
26. Lin R, Gewert D, Hiscott J, (1995) Differential transcriptional activation in vitro by NF-kappa B/Rel proteins. J Biol Chem 270: 3123-3131.
27. Thanos D, Maniatis T, (1995) Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83: 1091-1100.
28. Goh FG, Thomson SJ, Krausgruber T, Lanfrancotti A, Copley RR, et al. (2010) Beyond the enhanceosome: cluster of novel kappaB sites downstream of the human IFN-beta gene is essential for lipopolysaccharide-induced gene activation. Blood 116: 5580-5588.
29. van Essen D, Engist B, Natoli G, Saccani S, (2009) Two modes of transcriptional activation at native promoters by NF-kappaB p65. PLoS Biol 7: e73.
30. Huang H, Joazeiro CA, Bonfoco E, Kamada S, Leverson JD, et al. (2000) The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J Biol Chem 275: 26661-26664.
31. Suzuki Y, Nakabayashi Y, Takahashi R, (2001) Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci U S A 98: 8662-8667.
32. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC, (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16: 6914-6925.
33. Perrelet D, Ferri A, MacKenzie AE, Smith GM, Korneluk RG, et al. (2000) IAP family proteins delay motoneuron cell death in vivo. Eur J Neurosci 12: 2059-2067.
34. Tamura T, Yanai H, Savitsky D, Taniguchi T, (2008) The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 26: 535-584.
35. Bowie ML, Ibarra C, Seewalt VL, (2008) IRF-1 promotes apoptosis in p53-damaged basal-type human mammary epithelial cells: a model for early basal-type mammary carcinogenesis. Adv Exp Med Biol 617: 367-374.
36. Park J, Kim K, Lee EJ, Seo YJ, Lim SN, et al. (2007) Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis. Proc Natl Acad Sci U S A 104: 17028-17033.
37. Kimura T, Nakayama K, Penninger J, Kitagawa M, Harada H, et al. (1994) Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264: 1921-1924.
38. Gerlier D, Lyles DS, (2011) Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol Mol Biol Rev 75: 468-490 second page of table of contents.
39. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, et al. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997.
40. Faul EJ, Wanjalla CN, Suthar MS, Gale M, Wirblich C, et al. (2010) Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog 6: e1001016.
41. Nakamichi K, Saiki M, Sawada M, Takayama-Ito M, Yamamuro Y, et al. (2005) Rabies virus-induced activation of mitogen-activated protein kinase and NF-kappaB signaling pathways regulates expression of CXC and CC chemokine ligands in microglia. J Virol 79: 11801-11812.
42. Prehaud C, Megret F, Lafage M, Lafon M, (2005) Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J Virol 79: 12893-12904.
43. Faul EJ, Wanjalla CN, McGettigan JP, Schnell MJ, (2008) Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity. Virology 382: 226-238.
44. Rieder M, Conzelmann KK, (2009) Rhabdovirus evasion of the interferon system. J Interferon Cytokine Res 29: 499-509.
45. Lafon M, (2011) Evasive strategies in rabies virus infection. Adv Virus Res 79: 33-53.
46. Masatani T, Ito N, Shimizu K, Ito Y, Nakagawa K, et al. (2010) Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response. J Virol 84: 4002-4012.
47. Brzozka K, Finke S, Conzelmann KK, (2006) Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. J Virol 80: 2675-2683.
48. Vidy A, El Bougrini J, Chelbi-Alix MK, Blondel D, (2007) The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J Virol 81: 4255-4263.
49. Prehaud C, Wolff N, Terrien E, Lafage M, Megret F, et al. (2010) Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein. Sci Signal 3: ra5.
50. Rieder M, Brzozka K, Pfaller CK, Cox JH, Stitz L, et al. (2011) Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity. J Virol 85: 842-852.
51. Wiltzer L, Larrous F, Oksayan S, Ito N, Marsh GA, et al. (2012) Conservation of a unique mechanism of immune evasion across the Lyssavirus genus. J Virol 86 (18) (): 10194-9.
52. Kassis R, Larrous F, Estaquier J, Bourhy H, (2004) Lyssavirus matrix protein induces apoptosis by a TRAIL-dependent mechanism involving caspase-8 activation. J Virol 78: 6543-6555.
53. Gholami A, Kassis R, Real E, Delmas O, Guadagnini S, et al. (2008) Mitochondrial dysfunction in lyssavirus-induced apoptosis. J Virol 82: 4774-4784.
54. Larrous F, Gholami A, Mouhamad S, Estaquier J, Bourhy H, (2010) Two overlapping domains of a lyssavirus matrix protein that acts on different cell death pathways. J Virol 84: 9897-9906.
55. Kammouni W, Hasan L, Saleh A, Wood H, Fernyhough P, et al. (2012) Role of nuclear factor-κB in oxidative stress associated with rabies virus infection of adult rat dorsal root ganglion neurons. J Virol 86 (15) (): 8139-46.
56. de Los Santos T, Diaz-San Segundo F, Grubman MJ, (2007) Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J Virol 81: 12803-12815.
57. Neznanov N, Chumakov KM, Neznanova L, Almasan A, Banerjee AK, et al. (2005) Proteolytic cleavage of the p65-RelA subunit of NF-kappaB during poliovirus infection. J Biol Chem 280: 24153-24158.
58. El Mjiyad N, Bontems S, Gloire G, Horion J, Vandevenne P, et al. (2007) Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters. J Virol 81: 13092-13104.
59. Schuhmann KM, Pfaller CK, Conzelmann KK, (2011) The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity. J Virol 85: 3162-3171.
60. Delmas O, Holmes EC, Talbi C, Larrous F, Dacheux L, et al. (2008) Genomic diversity and evolution of the lyssaviruses. PLoS One 3: e2057.
61. Mendoza JA, Jacob Y, Cassonnet P, Favre M, (2006) Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3. J Virol 80: 12420-12424.
62. Schmidt-Ullrich R, Memet S, Lilienbaum A, Feuillard J, Raphael M, et al. (1996) NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. Development 122: 2117-2128.
63. Caignard G, Guerbois M, Labernardiere JL, Jacob Y, Jones LM, et al. (2007) Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling. Virology 368: 351-362.